TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up December 26, 2014
TCL Archive High Dose Chemotherapy Significantly Prolongs Survival In ECOG Clinical Trial November 28, 2008